IL6 and COVID-19: Current available approved drugs for treating patients with COVID-19 are remdesivir, dexamethasone, and immunomodulators including tocilizumab and sarilumab (IL-6 inhibitors), baricitinib (a Janus kinase (JAK) inhibitor), for hospitalized patients, and anti-SARS-CoV-2 monoclonal antibodies like sotrovimab and casirivimab for non-hospitalized adults.